71 related articles for article (PubMed ID: 24439672)
1. Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer.
Cai P; Guo W; Yuan H; Li Q; Wang W; Sun Y; Li X; Gu Y
Biomed Pharmacother; 2014 Apr; 68(3):285-90. PubMed ID: 24439672
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of SHP2 in gastric cancer.
Dong S; Li FQ; Zhang Q; Lv KZ; Yang HL; Gao Y; Yu JR
J Int Med Res; 2012; 40(6):2083-9. PubMed ID: 23321164
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules.
Liu SQ; Su YJ; Qin MB; Mao YB; Huang JA; Tang GD
Int J Oncol; 2013 Feb; 42(2):617-26. PubMed ID: 23232649
[TBL] [Abstract][Full Text] [Related]
4. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
Ambs S; Merriam WG; Bennett WP; Felley-Bosco E; Ogunfusika MO; Oser SM; Klein S; Shields PG; Billiar TR; Harris CC
Cancer Res; 1998 Jan; 58(2):334-41. PubMed ID: 9443414
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors.
Miyamoto D; Miyamoto M; Takahashi A; Yomogita Y; Higashi H; Kondo S; Hatakeyama M
Oncogene; 2008 Jun; 27(25):3508-15. PubMed ID: 18223690
[TBL] [Abstract][Full Text] [Related]
6. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
9. [Expression of candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colon cancer].
Chu DK; Zhang J; Shi H; Dong GL; Liu XP; Wang WZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):354-7. PubMed ID: 18636358
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and prognostic value of Nek2 protein expression in colon cancer.
Lu L; Zhai X; Yuan R
Int J Clin Exp Pathol; 2015; 8(11):15467-73. PubMed ID: 26823916
[TBL] [Abstract][Full Text] [Related]
11. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro.
Xie H; Huang S; Li W; Zhao H; Zhang T; Zhang D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):234-42. PubMed ID: 24439919
[TBL] [Abstract][Full Text] [Related]
13. [The expression and clinical significance of SphK1 and nuclear factor-κB p65 in human colon carcinoma].
Su YJ; Huang JA; Liu SQ; Huang JX; Zhong YY; Tang GD; Jiang HX
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):220-4. PubMed ID: 22781898
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer].
Li LR; Wan DS; Pan ZZ; Hardingham J; Rieger N; Hewett P; Zhou ZW; Chen G
Ai Zheng; 2004 Nov; 23(11 Suppl):1502-7. PubMed ID: 15566667
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer.
Huang ZM; Yang J; Shen XY; Zhang XY; Meng FS; Xu JT; Zhang BF; Gao HJ
J Dig Dis; 2009 Aug; 10(3):188-94. PubMed ID: 19659786
[TBL] [Abstract][Full Text] [Related]
16. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
[TBL] [Abstract][Full Text] [Related]
17. Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer.
Wang B; Li GX; Zhang SG; Wang Q; Wen YG; Tang HM; Zhou CZ; Xing AY; Fan JW; Yan DW; Qiu GQ; Yu ZH; Peng ZH
Exp Biol Med (Maywood); 2011 Nov; 236(11):1247-53. PubMed ID: 21998129
[TBL] [Abstract][Full Text] [Related]
18. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of humbug gene overexpression in stage II colon cancer.
Wang J; de la Monte SM; Sabo E; Kethu S; Tavares R; Branda M; Simao L; Wands JR; Resnick MB
Hum Pathol; 2007 Jan; 38(1):17-25. PubMed ID: 17020779
[TBL] [Abstract][Full Text] [Related]
20. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
Gomes EG; Connelly SF; Summy JM
Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
